Emanuela Berrino | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates	BIOORGANIC CHEMISTRY	2019
Novel approaches for designing drugs that interfere with pH regulation	EXPERT OPINION ON DRUG DISCOVERY	2019
Carbonic anhydrase inhibitors of different structures dilate pre-contracted porcine retinal arteries	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2019
New sulfonamides containing organometallicacylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY	2019
Rho-kinase inhibitors in the management of glaucoma	EXPERT OPINION ON THERAPEUTIC PATENTS	2019
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis	JOURNAL OF MEDICINAL CHEMISTRY	2019
SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX	BIOORGANIC CHEMISTRY	2018
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY	2018
1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity.	BIOORGANIC CHEMISTRY	2018
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes	JOURNAL OF MEDICINAL CHEMISTRY	2018
Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms with N'-aryl-N-hydroxy-ureas	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY	2018
Advances in microwave-assisted synthesis and the impact of novel drug discovery	EXPERT OPINION ON DRUG DISCOVERY	2018
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors	MOLECULES	2017

Progetti di Ricerca

CO-RM/NSAID molecular hybrids: a promising alliance to overcome limitations and enhance the anti-inflammatory and chemopreventive activities of a widespread used drug class